Alnylam Pharmaceuticals, Inc.
Amvuttra
Manufacturer:
Alnylam Pharmaceuticals, Inc.
Name:
Amvuttra
HCPCS Code Descriptor:
Injection, vutrisiran, 1 mg
Category:
J Code
HCPCS:
J0225
NDC(s):
71336-1003-01
Primary Type:
Genetic Disorder
Generic Status:
Single-Source
Route of Administration:
Subcutaneous
About:
Amvuttra is a Genetic Disorder drug manufactured by Alnylam Pharmaceuticals, Inc. and administered via the Subcutaneous route of administration. The J Code: J0225 is aligned to the drug Amvuttra.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/23
HCPCS Effective Date:
1/1/23
HCPCS Short Description:
Inj, vutrisiran, 1 mg
Billing and Coding Guide:
https://www.alnylamassist.com/sites/default/files/pdfdownloads/AMVUTTRA-vutrisiran-Billing-Coding-Physician.pdf
Patient Assistance:
https://www.alnylamassist.com/